| Tulsi C Sawlani, MD | |
|
7860 Burr St, Schererville, IN 46375-3402 | |
| (219) 864-2900 | |
| (219) 864-2910 |
| Full Name | Tulsi C Sawlani |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 50 Years |
| Location | 7860 Burr St, Schererville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912992736 | NPI | - | NPPES |
| 000000091546 | Other | IN | ANTHEM |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Hospitals Inc | Gary, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Imaging Center Llc | 5496714305 | 8 |
| N W Indiana Radiology Services, Pc | 9537065180 | 10 |
News Archive
A survey carried out among 250 pregnant women showed that 24% of them do not feel adequately informed by their gynaecologist, and almost half do not take part in any prenatal course. The study, prepared by the Head of the Obstetrics Department at the Hospital Clinico San Carlos in Madrid, Miguel Angel Herraiz, also showed that 80% of those surveyed prefer a "medicalised" birth, with epidural anaesthesia, to a natural birth.
Seattle Genetics Inc. has finally obtained the U.S. Food and Drugs Administration (FDA) nod for a second type of blood cancer drug. The FDA advisory committee voted 10-0 on Thursday to recommend accelerated approval of the drug, under the proposed trade name Adcetris, for anaplastic large cell lymphoma (ALCL). The panel earlier unanimously approved the drug for Hodgkin's lymphoma, another type of blood cancer.
Celgene Corporation announced non-GAAP net income of $294.6 million, or non-GAAP diluted earnings per share of $0.63 for the quarter ended March 31, 2010. Non-GAAP net income for the first quarter of 2009 was $205.1 million or non-GAAP diluted earnings per share of $0.44. Based on U.S. GAAP, Celgene reported net income of $234.4 million, or diluted earnings per share of $0.50 for the quarter ended March 31, 2010. GAAP net income for the first quarter of 2009 was $162.9 million, or diluted earnings per share of $0.35.
Rugby players take note: drinking high nitrate beetroot juice improves both sprint performance and decision-making during prolonged intermittent exercise such as rugby and football, according to scientists from the University of Exeter.
Allergan plc today announced the U.S. Food and Drug Administration has accepted for filing the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil).
› Verified 9 days ago
| Entity Name | N W Indiana Radiology Services, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386693364 PECOS PAC ID: 9537065180 Enrollment ID: O20031212000316 |
News Archive
A survey carried out among 250 pregnant women showed that 24% of them do not feel adequately informed by their gynaecologist, and almost half do not take part in any prenatal course. The study, prepared by the Head of the Obstetrics Department at the Hospital Clinico San Carlos in Madrid, Miguel Angel Herraiz, also showed that 80% of those surveyed prefer a "medicalised" birth, with epidural anaesthesia, to a natural birth.
Seattle Genetics Inc. has finally obtained the U.S. Food and Drugs Administration (FDA) nod for a second type of blood cancer drug. The FDA advisory committee voted 10-0 on Thursday to recommend accelerated approval of the drug, under the proposed trade name Adcetris, for anaplastic large cell lymphoma (ALCL). The panel earlier unanimously approved the drug for Hodgkin's lymphoma, another type of blood cancer.
Celgene Corporation announced non-GAAP net income of $294.6 million, or non-GAAP diluted earnings per share of $0.63 for the quarter ended March 31, 2010. Non-GAAP net income for the first quarter of 2009 was $205.1 million or non-GAAP diluted earnings per share of $0.44. Based on U.S. GAAP, Celgene reported net income of $234.4 million, or diluted earnings per share of $0.50 for the quarter ended March 31, 2010. GAAP net income for the first quarter of 2009 was $162.9 million, or diluted earnings per share of $0.35.
Rugby players take note: drinking high nitrate beetroot juice improves both sprint performance and decision-making during prolonged intermittent exercise such as rugby and football, according to scientists from the University of Exeter.
Allergan plc today announced the U.S. Food and Drug Administration has accepted for filing the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil).
› Verified 9 days ago
| Entity Name | Advanced Imaging Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033112990 PECOS PAC ID: 5496714305 Enrollment ID: O20041006001174 |
News Archive
A survey carried out among 250 pregnant women showed that 24% of them do not feel adequately informed by their gynaecologist, and almost half do not take part in any prenatal course. The study, prepared by the Head of the Obstetrics Department at the Hospital Clinico San Carlos in Madrid, Miguel Angel Herraiz, also showed that 80% of those surveyed prefer a "medicalised" birth, with epidural anaesthesia, to a natural birth.
Seattle Genetics Inc. has finally obtained the U.S. Food and Drugs Administration (FDA) nod for a second type of blood cancer drug. The FDA advisory committee voted 10-0 on Thursday to recommend accelerated approval of the drug, under the proposed trade name Adcetris, for anaplastic large cell lymphoma (ALCL). The panel earlier unanimously approved the drug for Hodgkin's lymphoma, another type of blood cancer.
Celgene Corporation announced non-GAAP net income of $294.6 million, or non-GAAP diluted earnings per share of $0.63 for the quarter ended March 31, 2010. Non-GAAP net income for the first quarter of 2009 was $205.1 million or non-GAAP diluted earnings per share of $0.44. Based on U.S. GAAP, Celgene reported net income of $234.4 million, or diluted earnings per share of $0.50 for the quarter ended March 31, 2010. GAAP net income for the first quarter of 2009 was $162.9 million, or diluted earnings per share of $0.35.
Rugby players take note: drinking high nitrate beetroot juice improves both sprint performance and decision-making during prolonged intermittent exercise such as rugby and football, according to scientists from the University of Exeter.
Allergan plc today announced the U.S. Food and Drug Administration has accepted for filing the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tulsi C Sawlani, MD 55 E 86th Ave, Po Box 10645, Merrillville, IN 46410-6382 Ph: (219) 769-1670 | Tulsi C Sawlani, MD 7860 Burr St, Schererville, IN 46375-3402 Ph: (219) 864-2900 |
News Archive
A survey carried out among 250 pregnant women showed that 24% of them do not feel adequately informed by their gynaecologist, and almost half do not take part in any prenatal course. The study, prepared by the Head of the Obstetrics Department at the Hospital Clinico San Carlos in Madrid, Miguel Angel Herraiz, also showed that 80% of those surveyed prefer a "medicalised" birth, with epidural anaesthesia, to a natural birth.
Seattle Genetics Inc. has finally obtained the U.S. Food and Drugs Administration (FDA) nod for a second type of blood cancer drug. The FDA advisory committee voted 10-0 on Thursday to recommend accelerated approval of the drug, under the proposed trade name Adcetris, for anaplastic large cell lymphoma (ALCL). The panel earlier unanimously approved the drug for Hodgkin's lymphoma, another type of blood cancer.
Celgene Corporation announced non-GAAP net income of $294.6 million, or non-GAAP diluted earnings per share of $0.63 for the quarter ended March 31, 2010. Non-GAAP net income for the first quarter of 2009 was $205.1 million or non-GAAP diluted earnings per share of $0.44. Based on U.S. GAAP, Celgene reported net income of $234.4 million, or diluted earnings per share of $0.50 for the quarter ended March 31, 2010. GAAP net income for the first quarter of 2009 was $162.9 million, or diluted earnings per share of $0.35.
Rugby players take note: drinking high nitrate beetroot juice improves both sprint performance and decision-making during prolonged intermittent exercise such as rugby and football, according to scientists from the University of Exeter.
Allergan plc today announced the U.S. Food and Drug Administration has accepted for filing the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil).
› Verified 9 days ago
Michael V. Azodo, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 7860 Burr St, Schererville, IN 46375 Phone: 219-864-2900 Fax: 219-864-2910 | |
Shailesh Bhatt, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 7860 Burr St, Schererville, IN 46375 Phone: 219-864-2900 Fax: 219-864-2910 | |
Amar Shah, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2323 Divac Dr, Schererville, IN 46375 Phone: 913-707-2320 | |
Murthy G Chimata, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 7860 Burr St, Schererville, IN 46375 Phone: 219-864-2900 Fax: 219-864-2910 | |
Ivan L Chermel, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 7860 Burr St, Schererville, IN 46375 Phone: 219-864-2900 Fax: 219-864-2910 | |
Tambarahalli A Nagaraja, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 7860 Burr St, Schererville, IN 46375 Phone: 219-864-2900 Fax: 219-864-2910 |